|
|
Volumn 33, Issue 7-8, 2001, Pages 3209-3210
|
|
Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
GANCICLOVIR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
ADULT;
AGE;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
IMMUNOREACTIVITY;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
INFECTION RATE;
KIDNEY BIOPSY;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SERODIAGNOSIS;
ADOLESCENT;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
AZATHIOPRINE;
CYCLOSPORINE;
CYTOMEGALOVIRUS INFECTIONS;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MIDDLE AGED;
MYCOPHENOLIC ACID;
POSTOPERATIVE COMPLICATIONS;
PREDNISOLONE;
RECOMBINANT FUSION PROTEINS;
|
|
EID: 0035670931
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02366-1 Document Type: Article |
|
Times cited : (13)
|
|
References (4)
|
